WILLIAM T BATES
Allopathic & Osteopathic Physicians|Family Medicine OOLTEWAH, TN NPI 1073552121
Browse related groups: Allopathic & Osteopathic Physicians|Family Medicine TN Novo Nordisk AS All categories
General Payments — all program years on this page
$10,063.10
- Category: General Payments
- Program years: PY2018–2024
- Record count: 711
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $1,790.04 across 94 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,790.04 | 94 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $372.67 | 21 |
| PFIZER INC. | $241.36 | 16 |
| Braeburn Inc. | $232.65 | 9 |
| ABBVIE INC. | $195.72 | 11 |
| Abbott Laboratories | $126.35 | 6 |
| Astellas Pharma US Inc | $60.84 | 2 |
| GlaxoSmithKline, LLC. | $55.06 | 3 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $51.59 | 3 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $50.03 | 2 |
| Bayer HealthCare Pharmaceuticals Inc. | $48.67 | 3 |
| OptiNose US, Inc. | $44.95 | 2 |
| Lundbeck LLC | $42.84 | 2 |
| Phathom Pharmaceuticals, Inc. | $32.58 | 2 |
| Amgen Inc. | $29.85 | 2 |
| Janssen Pharmaceuticals, Inc | $28.56 | 1 |
| Otsuka America Pharmaceutical, Inc. | $24.10 | 1 |
| iRhythm Technologies, Inc. | $20.48 | 1 |
| E.R. Squibb & Sons, L.L.C. | $20.27 | 1 |
| Insulet Corporation | $19.82 | 1 |
| Corcept Therapeutics | $19.54 | 1 |
| Merck Sharp & Dohme Corporation | $18.97 | 1 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $18.55 | 1 |
| ITI, Inc. | $17.86 | 1 |
| Lilly USA, LLC | $16.73 | 1 |
By program year
Records — PY2024 (94)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.